Frank has played an instrumental role in helping Merck conduct extensive modeling of the economic and market impact of a wide variety of legislative and regulatory proposals. He has a passion for using data to explain the underlying business environment and has done that for Merck since 2006. This work helps Merck and the industry
Kimberly serves as the project lead for GSK’s Inflation Reduction Act Planning and Implementation team, making her the single point of accountability. She coordinates GSK’s efforts to adapt to the law’s provisions and ensures the IRA’s impact is included in strategic and operating assessments. Kimberly also engages with government agencies and other groups to discuss
(Bristol-Myers Squibb) After his workday is over, Adam not only represents his hometown in the New Jersey state legislature, he is also an advocate for patients and the health care industry through his foundation. The Adam Taliaferro Foundation provides emotional, financial and educational support to individuals who suffer catastrophic head or spinal injuries and supports
Helen has helped build UCB’s external community-giving approach. She has long-term relationships with STEM organizations like BioBuilder, as well as organizations doing STEM work, like the Girl Scouts. She organizes service projects for UCB’s Atlanta employees and she even spent her volunteer days on a health mission trip in Honduras.
(Merck) – Denise is a leader who drives her company’s policy priorities and, in turn, our industry’s. From Part D to Health Care Reform Implementation, Denise helps partners understand the implications and how our collaborative work will, ultimately, help better patients’ lives.
As Executive Director of Global Supplier Diversity & Sustainability at BMS, Rondu is deeply involved with key organizations geared towards supplier diversity and has forged strong partnerships with over 25 international and national advocacy groups for small and diverse businesses. Additionally, he played a huge role in BMS’ COVID-19 response efforts. To support small/diverse suppliers
Dr. Wahdan advocates for advancing the health of women through science, research and accessible treatment options. Over the past few years, she has become a valued partner of Bayer’s Government Affairs team. She plays a vital role in engaging stakeholders and policymakers at every level of government on the changing landscape in women’s health care.
Troy Webb serves as VP Pharma Supply Chain & Strategy, Future Ready Transformation. In addition to overseeing the production of the company’s respiratory medications, he is also a great partner to GSK’s government relations team. He is willing to take the time to educate elected officials on the important lifesaving medications being produced by the
(Bristol-Myers Squibb) – Dinorah spearheaded an effort to educate BMS’ New Jersey workforce on the 2014 election and the importance of being politically active. Her efforts helped create greater awareness about the role government affairs and policy plays in supporting biopharmaceutical innovation and appropriate patient access to innovative medicines.
As a decisive advocate for clinical trial diversity, Kate has been an invaluable partner to Biogen’s Public Policy and Government Affairs team. She has helped spotlight key initiatives like Biogen’s partnership with the Morehouse School of Medicine and the launch of a new national minority trial index.